An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies
Clinical trial NCT00121732 · COMPLETED
Trial details
- NCT number
- NCT00121732
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2009-10-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.